Clinical Trial Update: YERVOY® Risk Minimization Tool Effectiveness Evaluation Survey

View source ↗

Summary

This clinical trial report indicates the completion of a risk minimization tool effectiveness evaluation for YERVOY (ipilimumab). The study focused on patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Yervoy (ipilimumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Advanced Melanoma | Status: COMPLETED